Clover Health

Clover Health Promotes Karen Soares to General Counsel

Retrieved on:

Wednesday, November 1, 2023

Dartmouth College, Associate, Toy, Medicare, Clover Health, Organization, Senior, Karen, Soares, Partnership, University, University of Chicago Law School, General counsel, Fried, Frank, Harris, Shriver & Jacobson, Clover

FRANKLIN, Tenn., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Clover Health (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced the appointment of Karen Soares as General Counsel, effective October 31, 2023.

Key Points:

FRANKLIN, Tenn., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Clover Health (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced the appointment of Karen Soares as General Counsel, effective October 31, 2023.
“Karen has been a tremendous asset to Clover over the years, providing strategic legal counsel and partnership as our business has continued to evolve.
Soares first joined Clover in 2018 as an Associate General Counsel, supporting the contracting, compliance, and product functions.
I am honored and excited to step into the role of Clover’s General Counsel as we continue on this important journey,” Soares said.

Clinician Use of Clover Assistant is Associated with Earlier Identification and Management of Diabetes

Retrieved on:

Thursday, October 12, 2023

Diagnosis, Health, Data science, A1C, Moyamoya disease, Ophthalmology, Retinopathy, Clover Health, Medicare, Chronic kidney disease, Medicine, Hypoglycemia, Patient, Pharmaceutical industry, Clover, Diabetes

FRANKLIN, Tenn., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Today, Clover Health (“Clover” or “the Company”) issued an analysis titled Clover Assistant Use and Diagnosis, Treatment, and Progression of Diabetes , which examines the association between use of the company’s flagship technology product, Clover Assistant (“CA”), and earlier physician identification and management of diabetes.

Key Points:

FRANKLIN, Tenn., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Today, Clover Health (“Clover” or “the Company”) issued an analysis titled Clover Assistant Use and Diagnosis, Treatment, and Progression of Diabetes , which examines the association between use of the company’s flagship technology product, Clover Assistant (“CA”), and earlier physician identification and management of diabetes.
“Early diagnosis and treatment of diabetes in the Medicare population is essential for preventing complications, improving overall health and well being, and reducing the economic burden associated with the condition,” said Dr. Kumar Dharmarajan, Chief Medical Officer of Clover Assistant.
“The diabetes comorbidities that CA lists are also important to address.
For example, I appreciate seeing evidence of peripheral arterial disease, because that reminds me to get the patient in for additional screening tests.

Clover Health to Host Virtual Clover Assistant Showcase on October 12, 2023

Retrieved on:

Wednesday, September 20, 2023

Q&A, Health care, Medicare, Clover Health, Patient, Chronic condition, Management, Disease, Nursing, Clover

FRANKLIN, Tenn., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will host a virtual Clover Assistant Showcase on Thursday, October 12, 2023 at 12:00 p.m. Eastern Time.

Key Points:

FRANKLIN, Tenn., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will host a virtual Clover Assistant Showcase on Thursday, October 12, 2023 at 12:00 p.m. Eastern Time.
The event will feature informative product demonstrations, followed by a live Q&A session with Clover executives and key members of the Clover Assistant team.
"Healthcare is at a pivotal moment, and Clover Assistant is our answer to the challenges we face," said Andrew Toy, Chief Executive Officer of Clover Health.
Clover Assistant Anywhere: Streamlining Clinician Workflows through EHR Integrations – hosted by Kevin Holub, Vice President of Product and Design.

InsurTech Market to grow by USD 61.75 billion from 2022 to 2027, Market driven by the need to improve business efficiency- Technavio

Retrieved on:

Monday, September 11, 2023

The potential growth difference for the insurtech market between 2022 and 2027 is USD 61.75 billion.

Key Points:

The potential growth difference for the insurtech market between 2022 and 2027 is USD 61.75 billion.
Insurance companies have recognized the potential of this data to optimize their expenses, enhance service delivery, and increase their revenues.
Leading insurance firms are facing intense competition as they strive to establish a dominant position and expand their market presence.
The need to improve business efficiency is one of the key drivers supporting the insurtech market growth in the UK.

Steve Spinner Appointed Chief Financial Officer at Autonomous Driving Software Company Plus

Retrieved on:

Wednesday, August 16, 2023

Plus, a global leader in highly automated and autonomous driving software solutions, announced today the appointment of Steven Spinner to Chief Financial Officer.

Key Points:

Plus, a global leader in highly automated and autonomous driving software solutions, announced today the appointment of Steven Spinner to Chief Financial Officer.
View the full release here: https://www.businesswire.com/news/home/20230816605519/en/
Steve Spinner Appointed Chief Financial Officer at Autonomous Driving Software Company Plus (Photo: Business Wire)
“With Steve’s strong financial acumen, combined with his deep understanding of how to operate successful technology companies, I am delighted for him to step into the CFO role to help accelerate our commercialization progress and global expansion,” said David Liu, Co-Founder and CEO of Plus.
“I am honored to serve as Chief Financial Officer at Plus during this pivotal time for the company and the autonomous driving industry,” Spinner said.
“Plus has established itself as a trailblazer, already delivering and deploying industry-leading commercial autonomous driving solutions to world-class fleets, Tier-1s and OEMs.

Clover Health Reports Strong Second Quarter 2023 Results; Highlights Improved Financial Performance and Guidance Ranges

Retrieved on:

Tuesday, August 8, 2023

Appendix Probi, EBITDA, Clover Health, Adjustment, MCR, GAAP, Table, SG, Bank statement, Bank, Beauty salon, Financial adviser, SG&A, Appendix

FRANKLIN, Tenn., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today reported financial results for the second quarter 2023. Management will host a conference call today at 5:00 p.m. ET to discuss its operating results and other business highlights.

Key Points:

Beginning with the third quarter of 2022, we updated the name of our Adjusted Operating Expenses (non-GAAP) metric to Adjusted SG&A (non-GAAP).
Please refer to footnote 4 for the updates to Adjusted SG&A (non-GAAP) beginning in the first quarter of 2023.
Adjusted SG&A (non-GAAP) and Adjusted EBITDA (non-GAAP) are non-GAAP financial measures.
Additional information about the Company's non-GAAP financial measures can be found under the caption "About Non-GAAP Financial Measures" below and in Appendix A.

Clinician Use of Clover Assistant is Associated with Significant Improvement in the Early Identification and Management of Chronic Kidney Disease

Retrieved on:

Tuesday, August 1, 2023

Clover, Chronic kidney disease, Data science, Stroke, Splenic infarction, Assistant, PTH, Clover Health, Patient, Acceleration, Diagnosis, Bias, Parathyroid hormone, CKD, Behavior, Conditional sentence, Pharmaceutical industry

FRANKLIN, Tenn., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Today, Clover Health (“Clover” or “the Company”) issued an analysis titled Clover Assistant Use and Diagnosis and Progression of Chronic Kidney Disease , which examines the association between use of the company’s flagship technology product, Clover Assistant (“CA”), and earlier physician identification and management of stage three chronic kidney disease (“CKD”).

Key Points:

FRANKLIN, Tenn., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Today, Clover Health (“Clover” or “the Company”) issued an analysis titled Clover Assistant Use and Diagnosis and Progression of Chronic Kidney Disease , which examines the association between use of the company’s flagship technology product, Clover Assistant (“CA”), and earlier physician identification and management of stage three chronic kidney disease (“CKD”).
“Our findings demonstrate that use of Clover Assistant supports earlier diagnosis and management of chronic disease,” said Dr. Kumar Dharmarajan, Chief Medical Officer of Clover Assistant.
“Importantly, we’re seeing that when doctors use Clover Assistant, not only is CKD diagnosed earlier in its progression, but the rate of kidney decline decelerates.
By removing this variable, we can confidently ascertain that the disease identification models within Clover Assistant are catalysts for improved disease management,” added Peter Loscutoff, Data Science Fellow at Clover.

HermesPR Drafts Shelley Risk as General Manager + Executive Vice President

Retrieved on:

Wednesday, July 12, 2023

Medicare Advantage, Medicaid, IPO, Nate, Head, Communication, Opioid use disorder, Medicare, Clover Health, Growth, PR, Risk, Yammer

Risk most recently served as Chief Marketing Officer at Crossroads , a 119-clinic, 9-state medication-assisted treatment provider for those struggling with opioid use disorder.

Key Points:

Risk most recently served as Chief Marketing Officer at Crossroads , a 119-clinic, 9-state medication-assisted treatment provider for those struggling with opioid use disorder.
She additionally brings a wealth of in-house and agency PR experience, with stints as Senior Vice President and General Manager at The Bulleit Group and as Director of Communications at Yammer.
New HermesPR clients in 2023 include Ophelia , Found , Talkiatry , Hopper Health , Laguna Health and CodaMetrix , among others.
I'm immensely proud and deeply motivated to help grow this agency into the market leader it was born to be."

Advize Health Is Pleased to Announce Rachel Jones as Its President

Retrieved on:

Tuesday, June 20, 2023

"I am excited to be joining the Advize Health team as it continues to evolve and expand its product and service offerings in the Program Integrity industry. Over the last ten years, Advize has consistently dedicated itself to combating healthcare fraud, waste and abuse, and I look forward to joining such a talented, passionate team of individuals that live by this mission every day." --Rachel Jones, President, Advize Health

Key Points:

PITTSBURGH, June 20, 2023 /PRNewswire-PRWeb/ -- Advize Health is pleased to announce Rachel Jones has joined the company as President.
"I am excited to be joining the Advize Health team as it continues to evolve and expand its product and service offerings in the Program Integrity industry.
Rachel is a high-energy executive with a proven record of building and leading effective teams, successfully shepherding programs, and establishing best practices.
In addition to her time at Clover Health, Rachel also spent over ten years at Highmark Blue Cross Blue Shield.

Clover Health Reports First Quarter 2023 Financial Results

Retrieved on:

Tuesday, May 9, 2023

Appendix Probi, EBITDA, Clover Health, Adjustment, MCR, GAAP, Table, SG, Bank statement, Bank, Beauty salon, Financial adviser, Appendix

FRANKLIN, Tenn., May 09, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today reported financial results for the first quarter 2023. Management will host a conference call today at 5:00 p.m. ET to discuss its operating results and other business highlights.

Key Points:

Please refer to footnote 4 for the updates to Adjusted SG&A (non-GAAP) beginning in the first quarter of 2023.
(3) Adjusted SG&A (non-GAAP) and Adjusted EBITDA (non-GAAP) are non-GAAP financial measures.
Additional information about the Company's non-GAAP financial measures can be found under the caption "About Non-GAAP Financial Measures" below and in Appendix A.
Additional information about the Company's non-GAAP financial measures can be found under the caption "About Non-GAAP Financial Measures" below and in Appendix A.